Ilaria Mascilini

Dr. Ilaria Mascilini

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in Children
Verified
Journal Article
Open access
PDF file
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
MCMarco Cascella
Marco Cascella
MLMarianna Leonardi
Marianna Leonardi
FMFederica Monaco
Federica Monaco
DNDavide Nocerino
Davide Nocerino
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo
Background: Juvenile primary fibromyalgia syndrome (JPFS) is a chronic musculoskeletal pain syndrome that affects children and adolescents. Methods: A VOSviewer-based bibliometric network analysis was performed by scanning the global literature on JPFS in the Web of Science (WOS) online database. The search string applied to identify the closest matching articles was “juvenile primary fibromyalgia syndrome (all field)”. Results: A total of 67 articles on JPFS were published from 1985 to March 2022, in the WOS. Regarding article types, 39 were research manuscripts, 16 reviews, 8 meeting abstracts, 2 letters, 1 book chapter, 1 correction, and 1 proceeding paper. The Quartile analysis demonstrated that 44% of papers were published in Q1, 37% in Q2, 8% in Q3, and 11% in Q4. Conclusions: Our analysis highlights that more efforts are warranted to increase the production of quality papers and enhance the connections between the various research groups. JFPS represents a research field still to be explored and which deserves greater investments to obtain quality scientific evidence.

27 July 2021 in Children
Verified
Journal Article
Open access
PDF file
GMGiuliano Marchetti
Giuliano Marchetti
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
FFFabio Ferrari
Fabio Ferrari
EFElisa Francia
Elisa Francia
IMIlaria Mascilini
Ilaria Mascilini
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo
We studied acute and chronic pain in pediatric patients who underwent thoracotomy for benign disease with a follow-up of at least three months. A telephone interview investigated about the presence of pain and the analgesic therapy in progress. The results were compared with the anesthetic technique, postoperative pain and the adequacy of pain therapy, both during the first week after surgery and at the time of interview. Fifty-six families consented to the study. The mean age of the children at surgery was 2.9 ± 4.5 years, while at the time of the interview was 6.5 ± 4.4 years. We performed different anesthetic strategies: Group A: general anesthesia (36 pts); Group B: general anesthesia and thoracic epidural (10 pts); Group C: general anesthesia and intercostal nerve block (10 pts). During the immediate postoperative period, 21 patients (37.5%) had at least one painful episode. At the time of interview, 3 children (5.3%) had moderate chronic neuropathic (burning) pain on surgical scar. There was no statistically significant difference between the type of anesthesia and the incidence and severity of acute post-operative pain. Despite its limitations, this study confirms the low incidence of chronic post-thoracotomy pain syndrome in children.

16 December 2021 in Children
Verified
Journal Article
Open access
PDF file
GMGiuliano Marchetti
Giuliano Marchetti
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
IMIlaria Mascilini
Ilaria Mascilini
EFElisa Francia
Elisa Francia
AIAntonella Insalaco
Antonella Insalaco
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo
Complex regional pain syndrome (CRPS) is still poorly understood. It is a pain disorder in which pain is disproportionate to the initial stimulus. There is no specific therapy for CRPS, but it can be managed by a combination of treatments. We report a 13-year-old girl with CRPS of the upper limb treated with somatic and abdominal acupuncture. She described a severe, pulsating pain in the left wrist and hand, with hypersensitivity, allodynia, a marked reduction in strength, and swelling and sweating at the level of the fingers. Pain began three months previously, after a trauma to the left wrist. The diagnostic tests performed were negative. At the first visit we recommended oral tramadol. During the first two sessions we used somatic acupuncture. At the third session, the girl reported suffering intolerable pain in the affected limb during the previous sessions, so we decided to use abdominal acupuncture. After 8 sessions of abdominal acupuncture the pain completely disappeared. Acupuncture could be a potential alternative when conservative therapy with physical and medical treatment fails, but more often parents and adolescents prefer this therapy since other comorbidities are often present in pediatric populations and abdominal acupuncture could be a valuable alternative aid.

27 February 2026 in Children
Verified
Journal Article
Open access
PDF file
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
CFCecilia Di Fabio
Cecilia Di Fabio
EFElisa Francia
Elisa Francia
IMIlaria Mascilini
Ilaria Mascilini
RTRiccardo Tarquini
Riccardo Tarquini
MCMarco Cascella
Marco Cascella
Remimazolam is an ultra-short-acting benzodiazepine developed according to the “soft drug” concept and characterized by rapid onset, predictable offset, organ-independent metabolism, and the availability of a specific antagonist. Due to these pharmacological features, this drug represents a particularly attractive option for pediatric anesthesia and sedation, a field in which traditional agents are often limited by hemodynamic instability, prolonged recovery, and adverse respiratory effects. This narrative review summarizes and discusses the current evidence regarding the use of remimazolam in pediatric patients, focusing on pharmacokinetics, pharmacodynamics, clinical applications, and safety. Available data indicate that remimazolam provides effective sedation and anesthesia in children across multiple settings, including induction of general anesthesia, non-operating room anesthesia, and intensive care unit sedation. Compared with propofol and midazolam, remimazolam is generally associated with greater hemodynamic stability, rapid recovery, reduced emergence delirium, and a favorable respiratory profile, while maintaining comparable efficacy. Intranasal administration has also shown promise as a premedication strategy for reducing preoperative anxiety, although it may occasionally be associated with pain. Even if remimazolam lacks intrinsic analgesic properties, its use appears to indirectly improve postoperative comfort by attenuating stress responses and emergence agitation. Despite encouraging results, pediatric use of remimazolam remains off-label in many countries, and evidence is still limited by small sample sizes and heterogeneous protocols. Further large-scale randomized controlled trials are needed to define optimal dosing strategies, long-term safety, and their definitive role in pediatric anesthetic and sedative practice.

1 March 2021 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
GMGiuliano Marchetti
Giuliano Marchetti
RPRoberto Pedone
Roberto Pedone
EFElisa Francia
Elisa Francia
IMIlaria Mascilini
Ilaria Mascilini
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo

4 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
CFCecilia Di Fabio
Cecilia Di Fabio
ASAndrea Scardaci
Andrea Scardaci
FSfrancesco smedile
francesco smedile
IMIlaria Mascilini
Ilaria Mascilini
MCMarco Cascella
Marco Cascella
Background: Metamizol (dipyrone) is a widely used analgesic and antipyretic drug in several European countries, particularly for postoperative pain management in both adult and pediatric populations. Methods: A narrative literature review was conducted to evaluate the efficacy, safety, and pharmacological mechanisms of metamizol in postoperative pain management. A comprehensive search of PubMed, Scopus, and the Cochrane Library was performed, and included articles published up to 2024. Search terms included metamizol, dipyrone and children. Results: The available evidence indicates that metamizol provides effective postoperative analgesia, with an efficacy comparable to that of other non-steroidal anti-inflammatory drugs and paracetamol. Pediatric studies similarly support its effectiveness in postoperative settings. Regarding safety, short-term use of metamizol appears to be well tolerated, with a low incidence of serious adverse events. Mechanistic studies suggest that metamizol exerts analgesic effects through a multimodal pathway, involving not only cyclo-oxygenase inhibition but also modulation of opioid and endocannabinoid systems. Conclusions: Metamizol represents an effective and generally well-tolerated option for short-term postoperative pain management in both adults and children when used under appropriate clinical monitoring. Current evidence supports a favorable benefit-to-risk balance for short-term use while highlighting the need for caution during prolonged therapy. Further large-scale, prospective studies are warranted to better define rare adverse events, clarify interindividual risk factors, and refine the understanding of their non-classical mechanisms of action.